Deasy Silvya Sari
Department of International Relations, Universitas Padjadjaran

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Indonesian Foreign Policy on Covid-19 Vaccine Procurement Deasy Silvya Sari; Mas Halimah Mas Halimah; Akim Akim; Ali Zahid Habibullah
Intermestic: Journal of International Studies Vol 7 No 1 (2022)
Publisher : Departemen Hubungan Internasional, Fakultas Ilmu Sosial dan Ilmu Politik, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/intermestic.v7n1.13

Abstract

This study aimed to explain Indonesia's foreign policy on Covid-19 vaccine procurement. It applied foreign policy concepts and qualitative methods to direct, collect, and analyze data. The data were collected through focus group discussions and structured interviews. The results showed that Indonesia's foreign policy on Covid-19 management had a national interest in protecting the public from contracting the virus. The country had 10 vaccines, including Sinovac, AstraZeneca, Pfizer, Moderna, Sinopharm, Johnson & Johnson, Sputnik V, CanSino, Novavax, and Zifivax. The procurement of the Covid-19 vaccine is carried out through bilateral and multilateral channels. The vaccine procurement financing was through buying and grants. The granting countries included China, Japan, the Netherlands, the United States, and the United Arab Emirates; while Covax Facility provided the multilateral grant.